If you are weighing treatment in China that involves imaging hardware, image guidance, a navigation system or an interventional consumable, one quiet question sits underneath every other consideration: is the device that will be used on you actually approved for the Chinese market? For that question there is a public, dated, checkable answer, and it does not require you to trust anyone's summary of it. China's drug and device regulator publishes medical-device registration approvals on a monthly schedule. The latest instalment relevant to this article, Announcement No. 101 of 2026 on the NMPA public-notice page, was posted on 15 October 2026 and lists 258 medical devices approved for registration in September 2026. This guide explains how an international patient can use that page as a routine self-check.
Why the Approval Check Comes Before the Price Comparison
Cost, wait time and language support are the questions international patients usually ask first. They are all reasonable. None of them, however, confirms whether the specific piece of technology described to you in a quote is one that the Chinese regulator has cleared for use in China.
That gap matters most for exactly the treatments people travel for: proton and heavy-ion centres, image-guided ablation, robotic or navigated implant surgery, specialised imaging, and newer cellular products where the hardware and consumables are as much a part of the story as the protocol. A broker's description is a marketing artefact. A dated registration announcement from the regulator, with a certificate number attached, is an administrative record. The second is worth more in a decision that involves your body.
There is also a practical benefit. When you walk into an appointment or reply to a care coordinator having already read the primary source, the conversation shifts from generalities to numbers. You can name the model, cite the certificate, and ask a pointed question. That tends to surface either a clean confirmation or an awkward silence, and both are useful information.
What the September 2026 Announcement Actually Says
The relevant facts, from the regulator's own notice page:
- Announcement No. 101 of 2026 was published on 15 October 2026 in the NMPA's public-notice index.
- It reports 258 medical devices approved for registration in September 2026.
- The detailed product list and the corresponding registration certificate numbers are contained in the announcement's attachment, not in the short notice text itself.
- The announcements in this series are issued month by month. Comparable announcements during 2025 covered roughly 225 to 308 devices per month, and the notice column itself lists 116 entries in total.
Two readings follow from those facts. First, the volume tells you the series is a live, continuously refreshed record rather than a one-off publication. If a device was cleared at any point in the recent period, there is a month whose announcement should mention it. Second, the attachment is where the work is. The headline count is context; the product names and certificate numbers in the file are the verifiable data. Plan on opening the attachment rather than reading the summary paragraph.
What a 258-Device Monthly List Does and Does Not Establish
A monthly registration announcement establishes approval for the products named in it, for that month. It does not function as a real-time inventory of what any particular hospital owns, and it does not certify that a cleared device is installed, maintained or operated competently in a specific department. Treat it as a legality check on the product, and keep clinical judgement where it belongs, with the treating physician. Specific treatment plans must be assessed by a licensed physician in person.
A Five-Step Self-Check You Can Do Before You Book
- Get the device identified in writing. Before checking anything, obtain the exact product name, model designation, manufacturer and — if the provider has it handy — the Chinese registration certificate number. Insist on the written form. A name you cannot spell is a name you cannot search.
- Open the notice index and go to the most recent month. Start with the latest monthly announcement, then work backwards. One month is never enough; the record is cumulative across months.
- Download the attachment and search the strings, not the ideas. Filter the file on the model number and on the manufacturer name. Search both in Latin characters and, if you have it, the Chinese product name, because listings are written in Chinese.
- Record the match. Note the announcement number, its publication date, the month of approval it covers, and the certificate number. That is a citation you can put in an email and ask the hospital to confirm.
- Escalate anything unresolved. If the device is not found in the months you searched, send the specific model and your findings to the hospital's international office or your coordinator and ask one narrow question: under which registration certificate is this exact model used in your department?
The whole exercise is maybe thirty minutes for a single device. For a trip that involves a procedure, that is a cheap insurance policy on a claim you would otherwise be taking on faith.
Verification Channels Compared: What Each One Can Prove
| Channel | What it can establish | What it cannot establish | How to use it |
|---|---|---|---|
| NMPA monthly registration announcement | That named devices were approved for registration in a stated month, with certificate numbers in the attachment | Whether a given hospital owns, installs or operates that model | Primary source; search month by month, record the certificate number |
| Hospital's international office | Which certificate covers the equipment actually used in that department | Nothing on its own until the number is cross-checked against the announcement | Ask in writing for the certificate number, then verify it yourself |
| Treating physician | Whether the technology is appropriate for your condition, and what alternatives exist | Regulatory marketing status of every consumable | Ask about clinical fit and alternatives; keep the legality check separate |
| Broker or agent | Quotable descriptions, scheduling help, translations | Independent proof of approval; verbal assurances are not records | Use their information as leads to verify, never as the verdict |
| OriEast coordination | A documentation request assembled and chased on your behalf, with findings summarised back to you | Same limits as any third party: it is not the regulator | Hand over the checklist and let the running-down be done locally |
Notice what is absent from that table. There is no row for "the agent's brochure" or "a screenshot of a certificate" as a stand-alone proof. The point of the monthly announcement is precisely that it removes the need to authenticate somebody else's document.
Questions Worth Putting to a Hospital or an Intermediary
These are short, and the answers are diagnostic:
- What is the exact model and manufacturer of the device used in this step of the plan?
- What is the Chinese registration certificate number for that model?
- If it was approved before this month, which monthly announcement covers it?
- Is the approval scope on the label narrower than what you are proposing for me?
- If this technology is not registered in China, what registered alternative would you use instead, and how does it differ?
- Who is the licensed physician responsible for operating it, and can I speak with them directly?
A provider that handles device questions well will answer them quickly and specifically. Evasion at this stage is information — it tells you something about the process you would be entering, before you have committed money or a travel window.
If the Device Is Not in the Announcement You Checked
Three readings are possible, and they are not interchangeable. The first and most common is simply timing: each instalment covers the month it reports, so an earlier clearance appears in an earlier notice, and the series runs back through the notice index. Search backwards before concluding anything.
The second is a naming mismatch. Model designations, manufacturer strings and Chinese product names can differ between marketing material and an administrative record. This is why the certificate number is the field worth chasing.
The third is that the product's status in China is not what the description implied. A monthly registration list cannot resolve every pathway by which a product may or may not reach a Chinese market, and this is the category where you should stop self-service entirely and ask for documentation in writing, ideally through a local party who can read the record with you. Do not accept an improvised comparison to another country's approval as a substitute.
Where This Fits in a Cancer, Proton or CAR-T Plan
For oncology and advanced-therapy travellers, device and product verification is one of several parallel checks. A proton or particle-therapy workup involves facility, beam delivery and imaging questions; a cell-therapy workup involves product, manufacturing and eligibility questions; and both involve documentation that arrives months before a device question ever becomes relevant. If you are assembling that kind of file, the complete medical tourism guide covers the sequencing, and the proton therapy guide and cancer treatment service page are where the modality-specific questions are set out. For cell therapy specifically, the CAR-T cost breakdown and the CAR-T service page separate the eligibility question from the access question. The same discipline applies to every one of them: get the identifier, check the public record, keep the citation.
Build the Check Into Your Timeline
| Stage | Device-related action | Why the timing matters |
|---|---|---|
| Research, several months out | Collect exact model names and manufacturer strings from written quotes | Identifiers must be requested while you can still change providers |
| Before committing payment | Search the monthly announcements backwards and record any matches | Verification is worth far more before money moves than after |
| At case review | Ask the hospital, in writing, for certificate numbers covering the equipment in the plan | Physicians and international offices answer best once your records are on file |
| Booking and travel preparation | Resolve open items; consider the medical visa guide for the practical side | Documentation gaps found here can still shift your dates |
| On arrival | Confirm nothing in the plan has been substituted at the last minute | Substitutions are the failure mode this check exists to catch |
A check like this is not a sign of distrust toward Chinese hospitals. It is the ordinary due diligence of a patient who intends to compare providers, and it is easier to do in advance than to unwind afterwards.
Let OriEast Run the Check With You
Reading a foreign-language regulatory attachment, chasing certificate numbers from a department that does not know you yet, and getting answers in writing is administrative work, and it is exactly the work our team does for international patients every week. OriEast can request the underlying documents, search the public record against them, translate what we find into plain English, and combine that with translation support, hospital appointments in Shanghai, hospital selection and day-to-day care coordination so a documentation gap never turns into a wasted trip.
If you are already weighing a specific plan, send the details through our case evaluation and our physicians will assess what you are considering, including which technologies in the plan are worth verifying. For a device question on its own, or a quote you would like checked line by line, contact us through the inquiry form and name the product. As always, any treatment decision depends on your individual case and must be made with a licensed physician after an in-person assessment — what a public register can settle is the narrower question of what is approved, and that is one you can now answer yourself.